LEARN THE METHOD
Evidence reading
Complex medicine questions become clearer when they are returned to checkable sources, study design and regulatory records. Every article identifies its editorial owner, review role, date and primary-source entry points.
Why one generic name cannot settle an originator or generic question
Fix the market, dosage form, route, strength and holder before reading reference, originator or generic records.
2026-08-13 · Editorial and review details →FOUNDATIONSOriginator and generic medicines: start with the right question
Do not turn “originator” and “generic” into a one-line ranking. Start with the exact active ingredient, form, market and current label, then read what each source can actually support.
2026-08-14 · Editorial and review details →R&D READINGFrom screening to medicine: how evidence accumulates
Candidate discovery, validation, clinical research, regulatory review and post-marketing monitoring answer different questions along one development path.
2026-08-14 · Editorial and review details →MANUFACTURING & QUALITYHow medicine quality is built beyond the laboratory
Quality is not a final test at the factory gate. It is a controlled system of materials, process, facilities, records and continual improvement.
2026-08-14 · Editorial and review details →PRACTICAL READINGHow to read a medicine label
A label is not marketing material. It is a versioned regulatory record of authorised use, risks, product presentation and updates.
2026-08-14 · Editorial and review details →EVIDENCE METHODWhy medicine education begins with primary regulatory sources
Papers and reporting may provide leads; approval records, labels and regulator communications are the starting point for checking a particular product in a particular market.
2026-08-14 · Editorial and review details →R&D & QUALITYHow to read global pharma's public R&D and quality material
Public material from Roche, Pfizer, GSK, Novartis, Lilly, Johnson & Johnson, Takeda and Boehringer Ingelheim can illuminate methods, but it does not itself prove a product's effectiveness, quality or marketing status.
2026-08-14 · Editorial and review details →DOSAGE FORMS & SAFETYInjections, oral medicines, patches and modified release: dosage form is identity
The same active ingredient does not necessarily mean the same medicine. Dosage form, route, strength, presentation and market are part of every comparison.
2026-08-14 · Editorial and review details →SAFER MEDICINE READINGReading a medicine label in larger print: mg, tablets, splitting, switching and combinations
Six practical questions make a small-print label easier to discuss: identify the exact product, understand what a strength means, check manipulation, prevent duplication and bring a complete medicine list to a pharmacist or prescriber.
2026-08-16 · Editorial and review details →SAFER MEDICINE READINGA family medicine list: what to bring when you need a pharmacist to check several medicines
Rather than relying on a remembered brand name, make a list of the name, per-unit strength, form, actual directions, prior reactions and every non-prescription product for a pharmacist or clinician to review.
2026-08-16 · Editorial and review details →GLOBAL MEDICINE LITERACYWhat the WHO Model List of Essential Medicines means: a public-health priority, not a personal prescription
The WHO Model List helps countries and health systems identify priority medicines. It is not a ranking of the world's best medicines, an originator-drug list or an individual treatment plan.
2026-09-04 · Editorial and review details →